The functional mechanisms of bevacizumab, via VEGF inhibition, include regression of existing microvessels to impede tumor growth, relative normalization of the surviving mature tumor vasculature, and inhibition of new vessel growth [10]. This evidence concerns the gene VEGFA and neoplasm.